Cargando…
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial
BACKGROUND: Patient satisfaction with antipsychotic treatment is important. Limited evidence suggests that satisfaction is associated with symptom improvement and compliance. Predictors of patient satisfaction with antipsychotic medication were examined in a study of patients with a recent exacerbat...
Autores principales: | Gharabawi, Georges M, Greenspan, Andrew, Rupnow, Marcia FT, Kosik-Gonzalez, Colette, Bossie, Cynthia A, Zhu, Young, Kalali, Amir H, Awad, A George |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626455/ https://www.ncbi.nlm.nih.gov/pubmed/17054789 http://dx.doi.org/10.1186/1471-244X-6-45 |
Ejemplares similares
-
Evaluating movement disorders in pediatric patients receiving risperidone: a comparison of spontaneous reports and research criteria for TD
por: Pandina, Gahan J, et al.
Publicado: (2007) -
Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia
por: Lenert, Leslie A, et al.
Publicado: (2005) -
Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs
por: Bossie, Cynthia A., et al.
Publicado: (2015) -
What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?
por: Kemp, Aaron S., et al.
Publicado: (2010) -
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval
por: Gharabawi, Georges M, et al.
Publicado: (2007)